Advisory Services Network’s Opus Genetics IRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-2
Closed 2635
2017
Q3
$0 Hold
2
﹤0.01% 2443
2017
Q2
$0 Hold
2
﹤0.01% 2394
2017
Q1
$1K Buy
+2
New +$259 ﹤0.01% 2143
2016
Q3
$0 Hold
2
﹤0.01% 2085
2016
Q2
$0 Sell
2
-46
-96% -$6.45K ﹤0.01% 1961
2016
Q1
$8K Hold
48
﹤0.01% 1140
2015
Q4
$8K Hold
48
﹤0.01% 1008
2015
Q3
$12K Buy
48
+2
+4% +$543 ﹤0.01% 881
2015
Q2
$13K Hold
46
﹤0.01% 834
2015
Q1
$16K Hold
46
﹤0.01% 747
2014
Q4
$16K Hold
46
0.01% 650
2014
Q3
$18K Hold
46
0.01% 261
2014
Q2
$19K Buy
+46
New +$20.9K 0.01% 244

Other funds holding IRD

Advisory Services Network's IRD Position: Q4 2017 in Review

Advisory Services Network sold out of Opus Genetics (IRD) in Q4 2017, closing a stake of 2 shares.

Advisory Services Network first reported a position in IRD in Q2 2014 and held it in 13 quarters. The position peaked at $19K in Q2 2014. 28 funds tracked by Wall St. Rank hold IRD as of Q4 2017.

  • Advisory Services Network reported no remaining Opus Genetics position as of Q4 2017 after selling out during the quarter.
  • Advisory Services Network sold 2 Opus Genetics shares in Q4 2017.
  • Advisory Services Network first reported a position in Opus Genetics in Q2 2014 and held it in 13 quarters.
  • Advisory Services Network's Opus Genetics position peaked at $19K in Q2 2014.
  • 28 funds tracked by Wall St. Rank held Opus Genetics as of Q4 2017.

Based on Advisory Services Network's 13F filing for Q4 2017, filed 8 Feb 2018.